When Should You Use Targeted DNA Sequencing?

Next-generation sequencing technology continues to make great strides in helping us understand the underlying causes of disease, but whole-genome sequencing presents several challenges to researchers in terms of cost, time, and other limitations. This 3-minute webinar details how targeted DNA sequencing overcomes these challenges, improving the utility of NGS for many research applications.

Next-generation sequencing technology continues to make great strides in helping us understand the underlying causes of disease, but whole-genome sequencing presents several challenges to researchers in terms of cost, time, and other limitations. This 3-minute webinar details how targeted DNA sequencing overcomes these challenges, improving the utility of NGS for many research applications.

Hide details

Dr. Raed Samara

Raed Samara is a scientist in the R&D Project Management department of QIAGEN at Frederick, where he manages and coordinates multiple life sciences product development projects across R&D, Marketing, and Operations teams. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.

Raed Samara is a scientist in the R&D Project Management department of QIAGEN at Frederick, where he manages and coordinates multiple life sciences product development projects across R&D, Marketing, and Operations teams. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.